CHIEF MEDICAL OFFICER
Sat, Jan 3, 2026
Jan 3
exercised or converted securities in ACLX
16,520 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +7172.60% (+42,605 shares)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ACLXArcellx, Inc.
Health CareBiotechnology